About me
Timothy W. Graul is a Senior Director in the CMC Advisory Office at Pfizer Inc. He received his B.S. in Chemistry at James Madison University and Ph.D. in Analytical Chemistry at Florida State University. After completing studies, Tim joined Pfizer Analytical R&D and supported the development of drug product formulations and drug substance synthetic routes. He is currently a member of the GRS CMC Advisory Office at Pfizer. Tim served as the PhRMA Deputy Topic lead on the ICH Q2/Q14 Expert Working Group and as an Industry Expert on the Implementation Working Group for the revised Q2 Guideline and new guideline, Q14. He is the co-lead of the ISPE PQLI group on Analytical Procedures.
